Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 25, 2011Clinical Cancer Research

Bevacizumab Has Differential and Dose-Dependent Effects on Glioma Blood Vessels and Tumor Cells

View Full Paper
Ask AI
Bookmark
Share

Authors

LBLouisa von BaumgartenLMU KlinikumDBDavid BruckerATAnca Tirniceru

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Baumgarten et al. (2011) studied this question.

synapsesocial.com/papers/6a83bea0ab0020f36262cf2ahttps://doi.org/10.1158/1078-0432.ccr-10-1868
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma2009 · 307 citations
  2. 2Antiangiogenic therapy in malignant gliomas2008 · 45 citations
  3. 3Bevacizumab and Recurrent Malignant Gliomas: A European Perspective2010 · 128 citations